<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC5614750</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC5614750.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">5614750</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">5614750</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">28975068</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1016/j.nicl.2017.09.007</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">S2213-1582(17)30221-8</article-id></all-ids><extracted-table><table-id>t0005</table-id><table-label>Table 1</table-label><table-caption>Summary of demographic and basic clinical data for all groups.</table-caption><table-wrap-foot>bvFTD, behavioral variant frontotemporal dementia; nvfPPA, non-fluent/agrammatic primary progressive aphasia; svPPA, semantic variant primary progressive aphasia, AD, Alzheimer's disease; ANOVA, analysis of variance; Smx, symptom; yr, years; M, male; F, female; MMSE, Mini-Mental State Examination score; CDRTot, clinical dementia rating score total; CDRBox, CDR box score.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="t0005" position="float" orientation="portrait"><label>Table 1</label><caption><p>Summary of demographic and basic clinical data for all groups.</p></caption><alt-text id="al0015">Table 1.</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Diagnosis</th><th colspan="2" rowspan="1">Controls<break/>n = 69<hr/></th><th colspan="2" rowspan="1">bvFTD<break/>n = 27<hr/></th><th colspan="2" rowspan="1">nfvPPA<break/>n = 14<hr/></th><th colspan="2" rowspan="1">svPPA<break/>n = 19<hr/></th><th colspan="2" rowspan="1">AD<break/>n = 19<hr/></th><th rowspan="2" colspan="1">ANOVA n = 148</th></tr><tr><th colspan="1" rowspan="1">Mean</th><th colspan="1" rowspan="1">SD</th><th colspan="1" rowspan="1">Mean</th><th colspan="1" rowspan="1">SD</th><th colspan="1" rowspan="1">Mean</th><th colspan="1" rowspan="1">SD</th><th colspan="1" rowspan="1">Mean</th><th colspan="1" rowspan="1">SD</th><th colspan="1" rowspan="1">Mean</th><th colspan="1" rowspan="1">SD</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Smx onset (age)</td><td colspan="1" rowspan="1">N/A</td><td colspan="1" rowspan="1">N/A</td><td colspan="1" rowspan="1">53.56</td><td colspan="1" rowspan="1">7.54</td><td colspan="1" rowspan="1">63.14</td><td colspan="1" rowspan="1">5.39</td><td colspan="1" rowspan="1">57.11</td><td colspan="1" rowspan="1">8.91</td><td colspan="1" rowspan="1">55.79</td><td colspan="1" rowspan="1">9.20</td><td colspan="1" rowspan="1">p = 0.0058<xref rid="tf0005" ref-type="table-fn">⁎</xref></td></tr><tr><td colspan="1" rowspan="1">Disease duration, baseline, yr</td><td colspan="1" rowspan="1">N/A</td><td colspan="1" rowspan="1">N/A</td><td colspan="1" rowspan="1">5.87</td><td colspan="1" rowspan="1">4.11</td><td colspan="1" rowspan="1">4.86</td><td colspan="1" rowspan="1">3.46</td><td colspan="1" rowspan="1">5.84</td><td colspan="1" rowspan="1">3.01</td><td colspan="1" rowspan="1">5.00</td><td colspan="1" rowspan="1">2.37</td><td colspan="1" rowspan="1">p = 0.6987</td></tr><tr><td colspan="1" rowspan="1">Age at baseline scan, yr</td><td colspan="1" rowspan="1">64.19</td><td colspan="1" rowspan="1">6.70</td><td colspan="1" rowspan="1">59.43</td><td colspan="1" rowspan="1">6.84</td><td colspan="1" rowspan="1">68.00</td><td colspan="1" rowspan="1">7.18</td><td colspan="1" rowspan="1">62.95</td><td colspan="1" rowspan="1">7.12</td><td colspan="1" rowspan="1">60.79</td><td colspan="1" rowspan="1">9.01</td><td colspan="1" rowspan="1">p = 0.0025<xref rid="tf0005" ref-type="table-fn">⁎</xref></td></tr><tr><td colspan="1" rowspan="1">Follow-up scan (age)</td><td colspan="1" rowspan="1">65.36</td><td colspan="1" rowspan="1">7.03</td><td colspan="1" rowspan="1">60.38</td><td colspan="1" rowspan="1">6.80</td><td colspan="1" rowspan="1">68.95</td><td colspan="1" rowspan="1">7.30</td><td colspan="1" rowspan="1">63.90</td><td colspan="1" rowspan="1">7.10</td><td colspan="1" rowspan="1">62.09</td><td colspan="1" rowspan="1">8.92</td><td colspan="1" rowspan="1">p = 0.0031<xref rid="tf0005" ref-type="table-fn">⁎</xref></td></tr><tr><td colspan="1" rowspan="1">Interscan interval, yr</td><td colspan="1" rowspan="1">1.17</td><td colspan="1" rowspan="1">0.60</td><td colspan="1" rowspan="1">0.95</td><td colspan="1" rowspan="1">0.22</td><td colspan="1" rowspan="1">0.95</td><td colspan="1" rowspan="1">0.35</td><td colspan="1" rowspan="1">0.95</td><td colspan="1" rowspan="1">0.37</td><td colspan="1" rowspan="1">1.30</td><td colspan="1" rowspan="1">0.47</td><td colspan="1" rowspan="1">p = 0.0387<xref rid="tf0005" ref-type="table-fn">⁎</xref></td></tr><tr><td colspan="1" rowspan="1">Sex, M/F, #</td><td colspan="1" rowspan="1">1.52</td><td colspan="1" rowspan="1">0.50</td><td colspan="1" rowspan="1">1.41</td><td colspan="1" rowspan="1">0.50</td><td colspan="1" rowspan="1">1.43</td><td colspan="1" rowspan="1">0.51</td><td colspan="1" rowspan="1">1.58</td><td colspan="1" rowspan="1">0.51</td><td colspan="1" rowspan="1">1.53</td><td colspan="1" rowspan="1">0.51</td><td colspan="1" rowspan="1">p = 0.7671</td></tr><tr><td colspan="1" rowspan="1">Education, yr</td><td colspan="1" rowspan="1">17.59</td><td colspan="1" rowspan="1">1.94</td><td colspan="1" rowspan="1">15.78</td><td colspan="1" rowspan="1">2.95</td><td colspan="1" rowspan="1">16.46</td><td colspan="1" rowspan="1">2.79</td><td colspan="1" rowspan="1">16.50</td><td colspan="1" rowspan="1">2.71</td><td colspan="1" rowspan="1">16.83</td><td colspan="1" rowspan="1">3.22</td><td colspan="1" rowspan="1">p = 0.0262<xref rid="tf0005" ref-type="table-fn">⁎</xref></td></tr><tr><td colspan="1" rowspan="1">MMSE baseline</td><td colspan="1" rowspan="1">29.52</td><td colspan="1" rowspan="1">0.68</td><td colspan="1" rowspan="1">24.81</td><td colspan="1" rowspan="1">3.62</td><td colspan="1" rowspan="1">23.64</td><td colspan="1" rowspan="1">8.44</td><td colspan="1" rowspan="1">22.42</td><td colspan="1" rowspan="1">7.86</td><td colspan="1" rowspan="1">21.94</td><td colspan="1" rowspan="1">6.16</td><td colspan="1" rowspan="1">p &lt; 0.00001<xref rid="tf0005" ref-type="table-fn">⁎</xref></td></tr><tr><td colspan="1" rowspan="1">MMSE follow-up</td><td colspan="1" rowspan="1">27.98</td><td colspan="1" rowspan="1">7.29</td><td colspan="1" rowspan="1">19.78</td><td colspan="1" rowspan="1">9.94</td><td colspan="1" rowspan="1">18.08</td><td colspan="1" rowspan="1">12.23</td><td colspan="1" rowspan="1">18.89</td><td colspan="1" rowspan="1">6.98</td><td colspan="1" rowspan="1">14.26</td><td colspan="1" rowspan="1">10.96</td><td colspan="1" rowspan="1">p &lt; 0.00001<xref rid="tf0005" ref-type="table-fn">⁎</xref></td></tr><tr><td colspan="1" rowspan="1">CDRTot baseline</td><td colspan="1" rowspan="1">0.00</td><td colspan="1" rowspan="1">0.00</td><td colspan="1" rowspan="1">6.80</td><td colspan="1" rowspan="1">2.80</td><td colspan="1" rowspan="1">2.40</td><td colspan="1" rowspan="1">2.60</td><td colspan="1" rowspan="1">4.10</td><td colspan="1" rowspan="1">1.80</td><td colspan="1" rowspan="1">5.30</td><td colspan="1" rowspan="1">0.40</td><td colspan="1" rowspan="1">p &lt; 0.0001<xref rid="tf0005" ref-type="table-fn">⁎</xref></td></tr><tr><td colspan="1" rowspan="1">CDRBox baseline</td><td colspan="1" rowspan="1">0.00</td><td colspan="1" rowspan="1">0.00</td><td colspan="1" rowspan="1">1.20</td><td colspan="1" rowspan="1">0.60</td><td colspan="1" rowspan="1">0.50</td><td colspan="1" rowspan="1">0.50</td><td colspan="1" rowspan="1">0.70</td><td colspan="1" rowspan="1">0.40</td><td colspan="1" rowspan="1">0.90</td><td colspan="1" rowspan="1">2.00</td><td colspan="1" rowspan="1">p &lt; 0.0001<xref rid="tf0005" ref-type="table-fn">⁎</xref></td></tr><tr><td colspan="1" rowspan="1">CDRTot follow-up</td><td colspan="1" rowspan="1">0.00</td><td colspan="1" rowspan="1">0.00</td><td colspan="1" rowspan="1">8.50</td><td colspan="1" rowspan="1">3.00</td><td colspan="1" rowspan="1">3.40</td><td colspan="1" rowspan="1">3.80</td><td colspan="1" rowspan="1">5.50</td><td colspan="1" rowspan="1">2.70</td><td colspan="1" rowspan="1">5.60</td><td colspan="1" rowspan="1">3.90</td><td colspan="1" rowspan="1">p &lt; 0.0001<xref rid="tf0005" ref-type="table-fn">⁎</xref></td></tr><tr><td colspan="1" rowspan="1">CDRBox follow-up</td><td colspan="1" rowspan="1">0.00</td><td colspan="1" rowspan="1">0.00</td><td colspan="1" rowspan="1">1.50</td><td colspan="1" rowspan="1">0.60</td><td colspan="1" rowspan="1">0.70</td><td colspan="1" rowspan="1">0.60</td><td colspan="1" rowspan="1">1.00</td><td colspan="1" rowspan="1">0.50</td><td colspan="1" rowspan="1">0.70</td><td colspan="1" rowspan="1">1.50</td><td colspan="1" rowspan="1">p &lt; 0.0001<xref rid="tf0005" ref-type="table-fn">⁎</xref></td></tr></tbody></table><table-wrap-foot><fn><p>bvFTD, behavioral variant frontotemporal dementia; nvfPPA, non-fluent/agrammatic primary progressive aphasia; svPPA, semantic variant primary progressive aphasia, AD, Alzheimer's disease; ANOVA, analysis of variance; Smx, symptom; yr, years; M, male; F, female; MMSE, Mini-Mental State Examination score; CDRTot, clinical dementia rating score total; CDRBox, CDR box score.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0005"><label>⁎</label><p id="np0005">Significant differences p &lt; 0.05.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Summary of demographic and basic clinical data for all groups.</div>Table 1.<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Diagnosis</th><th colspan="2">Controlsn = 69</th><th colspan="2">bvFTDn = 27</th><th colspan="2">nfvPPAn = 14</th><th colspan="2">svPPAn = 19</th><th colspan="2">ADn = 19</th><th rowspan="2">ANOVA n = 148</th></tr><tr><th>Mean</th><th>SD</th><th>Mean</th><th>SD</th><th>Mean</th><th>SD</th><th>Mean</th><th>SD</th><th>Mean</th><th>SD</th></tr></thead><tbody><tr><td>Smx onset (age)</td><td>N/A</td><td>N/A</td><td>53.56</td><td>7.54</td><td>63.14</td><td>5.39</td><td>57.11</td><td>8.91</td><td>55.79</td><td>9.20</td><td>p = 0.0058???</td></tr><tr><td>Disease duration, baseline, yr</td><td>N/A</td><td>N/A</td><td>5.87</td><td>4.11</td><td>4.86</td><td>3.46</td><td>5.84</td><td>3.01</td><td>5.00</td><td>2.37</td><td>p = 0.6987</td></tr><tr><td>Age at baseline scan, yr</td><td>64.19</td><td>6.70</td><td>59.43</td><td>6.84</td><td>68.00</td><td>7.18</td><td>62.95</td><td>7.12</td><td>60.79</td><td>9.01</td><td>p = 0.0025???</td></tr><tr><td>Follow-up scan (age)</td><td>65.36</td><td>7.03</td><td>60.38</td><td>6.80</td><td>68.95</td><td>7.30</td><td>63.90</td><td>7.10</td><td>62.09</td><td>8.92</td><td>p = 0.0031???</td></tr><tr><td>Interscan interval, yr</td><td>1.17</td><td>0.60</td><td>0.95</td><td>0.22</td><td>0.95</td><td>0.35</td><td>0.95</td><td>0.37</td><td>1.30</td><td>0.47</td><td>p = 0.0387???</td></tr><tr><td>Sex, M/F, #</td><td>1.52</td><td>0.50</td><td>1.41</td><td>0.50</td><td>1.43</td><td>0.51</td><td>1.58</td><td>0.51</td><td>1.53</td><td>0.51</td><td>p = 0.7671</td></tr><tr><td>Education, yr</td><td>17.59</td><td>1.94</td><td>15.78</td><td>2.95</td><td>16.46</td><td>2.79</td><td>16.50</td><td>2.71</td><td>16.83</td><td>3.22</td><td>p = 0.0262???</td></tr><tr><td>MMSE baseline</td><td>29.52</td><td>0.68</td><td>24.81</td><td>3.62</td><td>23.64</td><td>8.44</td><td>22.42</td><td>7.86</td><td>21.94</td><td>6.16</td><td>p &lt; 0.00001???</td></tr><tr><td>MMSE follow-up</td><td>27.98</td><td>7.29</td><td>19.78</td><td>9.94</td><td>18.08</td><td>12.23</td><td>18.89</td><td>6.98</td><td>14.26</td><td>10.96</td><td>p &lt; 0.00001???</td></tr><tr><td>CDRTot baseline</td><td>0.00</td><td>0.00</td><td>6.80</td><td>2.80</td><td>2.40</td><td>2.60</td><td>4.10</td><td>1.80</td><td>5.30</td><td>0.40</td><td>p &lt; 0.0001???</td></tr><tr><td>CDRBox baseline</td><td>0.00</td><td>0.00</td><td>1.20</td><td>0.60</td><td>0.50</td><td>0.50</td><td>0.70</td><td>0.40</td><td>0.90</td><td>2.00</td><td>p &lt; 0.0001???</td></tr><tr><td>CDRTot follow-up</td><td>0.00</td><td>0.00</td><td>8.50</td><td>3.00</td><td>3.40</td><td>3.80</td><td>5.50</td><td>2.70</td><td>5.60</td><td>3.90</td><td>p &lt; 0.0001???</td></tr><tr><td>CDRBox follow-up</td><td>0.00</td><td>0.00</td><td>1.50</td><td>0.60</td><td>0.70</td><td>0.60</td><td>1.00</td><td>0.50</td><td>0.70</td><td>1.50</td><td>p &lt; 0.0001???</td></tr></tbody></table></div>bvFTD, behavioral variant frontotemporal dementia; nvfPPA, non-fluent/agrammatic primary progressive aphasia; svPPA, semantic variant primary progressive aphasia, AD, Alzheimer's disease; ANOVA, analysis of variance; Smx, symptom; yr, years; M, male; F, female; MMSE, Mini-Mental State Examination score; CDRTot, clinical dementia rating score total; CDRBox, CDR box score.⁎Significant differences p &lt; 0.05.</transformed-table></extracted-table><extracted-table><table-id>t0010</table-id><table-label>Table 2</table-label><table-caption>Illustrated in these tables are sample sizes based on annualized rates of change in FA (2.A) and MD (2.B) in select regions of interest where at least one group had a sample size below 100. A total of 48 regions were investigated. Values under 100 are highlighted in yellow for nfvPPA, purple for svPPA, and blue for AD. Sample sizes are in an ascending order and grouped by pathology. The best sample size for each group is bolded. The region with the overall best sample size, all FTD groups included is the corpus callosum, bordered in red.FA, fractional anisotropy; MD, mean diffusivity; ROI, region of interest; CC, corpus callosum; fasc., fascicule; Sup, superior; Ant, anterior; L, left; R, right; bvFTD, behavioral variant frontotemporal dementia; nfvPPA, non-fluent/agrammatic primary progressive aphasia; svPPA, semantic variant primary progressive aphasia, AD, Alzheimer's disease.</table-caption><table-wrap-foot/><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="t0010" position="float" orientation="portrait"><label>Table 2</label><caption><p>Illustrated in these tables are sample sizes based on annualized rates of change in FA (2.A) and MD (2.B) in select regions of interest where at least one group had a sample size below 100. A total of 48 regions were investigated. Values under 100 are highlighted in yellow for nfvPPA, purple for svPPA, and blue for AD. Sample sizes are in an ascending order and grouped by pathology. The best sample size for each group is bolded. The region with the overall best sample size, all FTD groups included is the corpus callosum, bordered in red.</p><p>FA, fractional anisotropy; MD, mean diffusivity; ROI, region of interest; CC, corpus callosum; fasc., fascicule; Sup, superior; Ant, anterior; L, left; R, right; bvFTD, behavioral variant frontotemporal dementia; nfvPPA, non-fluent/agrammatic primary progressive aphasia; svPPA, semantic variant primary progressive aphasia, AD, Alzheimer's disease.</p></caption><alt-text id="al0020">Table 2</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="t1.jpg"/></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Illustrated in these tables are sample sizes based on annualized rates of change in FA (2.A) and MD (2.B) in select regions of interest where at least one group had a sample size below 100. A total of 48 regions were investigated. Values under 100 are highlighted in yellow for nfvPPA, purple for svPPA, and blue for AD. Sample sizes are in an ascending order and grouped by pathology. The best sample size for each group is bolded. The region with the overall best sample size, all FTD groups included is the corpus callosum, bordered in red.FA, fractional anisotropy; MD, mean diffusivity; ROI, region of interest; CC, corpus callosum; fasc., fascicule; Sup, superior; Ant, anterior; L, left; R, right; bvFTD, behavioral variant frontotemporal dementia; nfvPPA, non-fluent/agrammatic primary progressive aphasia; svPPA, semantic variant primary progressive aphasia, AD, Alzheimer's disease.</div>Table 2<div xmlns="http://www.w3.org/1999/xhtml"><img src=""/></div></transformed-table></extracted-table><extracted-table><table-id>t0015</table-id><table-label>Table 3</table-label><table-caption>Sample sizes based on global cognitive and functional scores.</table-caption><table-wrap-foot>Illustrated in this table are sample sizes based on annualized rates of change in functional status and cognitive performance. Sample sizes &lt; 100 and highlighted for each pathological group; grey for bvFTD and purple for svPPA.CDR_Total, total clinical dementia rating score; CDR_BoxScore, box score clinical dementia rating score; bvFTD, behavioral variant frontotemporal dementia; nvfPPA, non-fluent/agrammatic primary progressive aphasia; svPPA, semantic variant primary progressive aphasia, AD, Alzheimer's disease.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="t0015" position="float" orientation="portrait"><label>Table 3</label><caption><p>Sample sizes based on global cognitive and functional scores.</p></caption><alt-text id="al0025">Table 3.</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="t2.jpg"/><table-wrap-foot><fn id="sp0040"><p>Illustrated in this table are sample sizes based on annualized rates of change in functional status and cognitive performance. Sample sizes &lt; 100 and highlighted for each pathological group; grey for bvFTD and purple for svPPA.</p></fn><fn id="sp0045"><p>CDR_Total, total clinical dementia rating score; CDR_BoxScore, box score clinical dementia rating score; bvFTD, behavioral variant frontotemporal dementia; nvfPPA, non-fluent/agrammatic primary progressive aphasia; svPPA, semantic variant primary progressive aphasia, AD, Alzheimer's disease.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Sample sizes based on global cognitive and functional scores.</div>Table 3.<div xmlns="http://www.w3.org/1999/xhtml"><img src=""/></div>Illustrated in this table are sample sizes based on annualized rates of change in functional status and cognitive performance. Sample sizes &lt; 100 and highlighted for each pathological group; grey for bvFTD and purple for svPPA.CDR_Total, total clinical dementia rating score; CDR_BoxScore, box score clinical dementia rating score; bvFTD, behavioral variant frontotemporal dementia; nvfPPA, non-fluent/agrammatic primary progressive aphasia; svPPA, semantic variant primary progressive aphasia, AD, Alzheimer's disease.</transformed-table></extracted-table><extracted-table><table-id>t0020</table-id><table-label>Table 4</table-label><table-caption>Summary table of best sample size by group measure of change.</table-caption><table-wrap-foot>Illustrated above a composite table of the change metric with the resultant smallest sample size for at least one group (bvFTD in grey, nfvPPA in yellow, svPPA in purple, and AD in blue, as well as across groups, bordered in red.)CDR_BoxScore, box score clinical dementia rating score; MD, mean diffusivity; bvFTD, behavioral variant frontotemporal dementia; nvfPPA, non-fluent/agrammatic primary progressive aphasia; svPPA, semantic variant primary progressive aphasia, AD, Alzheimer's disease; FA, fractional anisotropy; MD, mean diffusivity; L, left; SLF, superior longitudinal fasciculus; CC, corpus callosum.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="t0020" position="float" orientation="portrait"><label>Table 4</label><caption><p>Summary table of best sample size by group measure of change.</p></caption><alt-text id="al0030">Table 4.</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="t3.jpg"/><table-wrap-foot><fn id="sp0055"><p>Illustrated above a composite table of the change metric with the resultant smallest sample size for at least one group (bvFTD in grey, nfvPPA in yellow, svPPA in purple, and AD in blue, as well as across groups, bordered in red.)</p></fn><fn id="sp0060"><p>CDR_BoxScore, box score clinical dementia rating score; MD, mean diffusivity; bvFTD, behavioral variant frontotemporal dementia; nvfPPA, non-fluent/agrammatic primary progressive aphasia; svPPA, semantic variant primary progressive aphasia, AD, Alzheimer's disease; FA, fractional anisotropy; MD, mean diffusivity; L, left; SLF, superior longitudinal fasciculus; CC, corpus callosum.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 4<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Summary table of best sample size by group measure of change.</div>Table 4.<div xmlns="http://www.w3.org/1999/xhtml"><img src=""/></div>Illustrated above a composite table of the change metric with the resultant smallest sample size for at least one group (bvFTD in grey, nfvPPA in yellow, svPPA in purple, and AD in blue, as well as across groups, bordered in red.)CDR_BoxScore, box score clinical dementia rating score; MD, mean diffusivity; bvFTD, behavioral variant frontotemporal dementia; nvfPPA, non-fluent/agrammatic primary progressive aphasia; svPPA, semantic variant primary progressive aphasia, AD, Alzheimer's disease; FA, fractional anisotropy; MD, mean diffusivity; L, left; SLF, superior longitudinal fasciculus; CC, corpus callosum.</transformed-table></extracted-table></extracted-tables-set>